Podcast 68: Treatment of Male Hypogonadism

41:28
 
Share
 

Manage episode 268999295 series 1438257
By Dr. Kevin and Dr. Dimitre: Canadian Medical Educators, Dr. Kevin, and Dr. Dimitre: Canadian Medical Educators. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Dear Listeners,

As a follow up to podcast 67, Eric Harvey, a 3rd year Mcgill medical student, is joining the Primary Medicine Podcast to go over the treatment approach for male hypogonadism.

It is important to consider both benefits and risks of testosterone therapy, before initiating treatment. The clearest benefit is to men with abnormally low serum testosterone levels who present with sexual dysfunction. The clearest risks are erythrocytosis, cardiac, and prostate disease. It is important to do routine testosterone, lipids, hematocrit, and PSA levels.

There are many different forms of testosterone therapy ranging from oral to intramuscular. The choice of medication is based on patient preference, cost, and side effect profile.

We end the podcast with a brief discussion about Eric and his classmate’s experiences during the COVID shutdown. A situation without a recent historical precedent.

Please visit the membership page!

Posted on 5/08/2020 by Dr. Dimitre

This Podcast is eligible for 0,5 Mainpro Non-Certified credits. Login to CFPC to claim them.

The post Podcast 68: Treatment of Male Hypogonadism appeared first on Primary Medicine Podcast.

75 episodes